WO2011033163A3 - Complejos metálicos miméticos de sod - Google Patents

Complejos metálicos miméticos de sod Download PDF

Info

Publication number
WO2011033163A3
WO2011033163A3 PCT/ES2010/070607 ES2010070607W WO2011033163A3 WO 2011033163 A3 WO2011033163 A3 WO 2011033163A3 ES 2010070607 W ES2010070607 W ES 2010070607W WO 2011033163 A3 WO2011033163 A3 WO 2011033163A3
Authority
WO
WIPO (PCT)
Prior art keywords
sod
metal complexes
macrocyclic
present
complexes
Prior art date
Application number
PCT/ES2010/070607
Other languages
English (en)
French (fr)
Other versions
WO2011033163A2 (es
Inventor
Enrique GARCÍA-ESPAÑA MONSONÍS
Mª Paz CLARES GARCÍA
Salvador Blasco Llopis
Concepción SOTO SORIANO
Jorge GONZÁLEZ GARCÍA
Begoña VERDEJO VIU
Original Assignee
Universitat De Valencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat De Valencia filed Critical Universitat De Valencia
Priority to US13/497,135 priority Critical patent/US9145386B2/en
Priority to EP10816744.6A priority patent/EP2492270B1/en
Priority to ES10816744.6T priority patent/ES2569239T3/es
Publication of WO2011033163A2 publication Critical patent/WO2011033163A2/es
Publication of WO2011033163A3 publication Critical patent/WO2011033163A3/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G47/00—Compounds of rhenium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención comprende un procedimiento para sintetizar complejos metálicos a partir de compuestos macrocíclicos poliazapiridinofanos,caracterizados por ser miméticos de la enzima superóxido dismutasa (SOD). Además la presente invención hace referencia a los propios compuestos metálicos macrocíclicos poliazapiridinofanos, a los complejos metálicos formados a partir de ellos y al uso de éstos en terapia para el tratamiento de enfermedades cuya etiología se basa en anomalías de la actividad de la SOD endógena, principalmente como antiinflamatorios, analgésicos y antioxidantes protectores del estrés oxidativo celular.
PCT/ES2010/070607 2009-09-21 2010-09-20 Complejos metálicos miméticos de sod WO2011033163A2 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/497,135 US9145386B2 (en) 2009-09-21 2010-09-20 SOD-imitating metal complexes
EP10816744.6A EP2492270B1 (en) 2009-09-21 2010-09-20 Sod-imitating metal complexes
ES10816744.6T ES2569239T3 (es) 2009-09-21 2010-09-20 Complejos metálicos miméticos de SOD

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200930712A ES2355784B1 (es) 2009-09-21 2009-09-21 Complejos metalicos mimeticos de sod
ESP200930712 2009-09-21

Publications (2)

Publication Number Publication Date
WO2011033163A2 WO2011033163A2 (es) 2011-03-24
WO2011033163A3 true WO2011033163A3 (es) 2011-07-07

Family

ID=43736319

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2010/070607 WO2011033163A2 (es) 2009-09-21 2010-09-20 Complejos metálicos miméticos de sod

Country Status (4)

Country Link
US (1) US9145386B2 (es)
EP (1) EP2492270B1 (es)
ES (2) ES2355784B1 (es)
WO (1) WO2011033163A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2414291B2 (es) * 2011-12-16 2014-02-13 Universitat De Valencia Compuestos macrocíclicos de tipo escorpiando y su uso como antiparasitarios.
ES2543850B1 (es) * 2014-02-24 2016-06-16 Universitat De Valencia Uso de complejos metálicos miméticos de SOD como agentes alimentarios y como cosméticos
WO2019007996A1 (en) 2017-07-04 2019-01-10 Bionos Biotech, S.L USE OF METALLIC COMPLEXES OF MACROAZAPYRIDINOPHANES IN THE TREATMENT OF DISEASES

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794371B1 (en) * 1999-10-18 2004-09-21 The Dow Chemical Company Aminoalkylenephosphonates for treatment of bone disorders
US20070298354A1 (en) * 2006-06-27 2007-12-27 Ni Ding Carbon coating on an implantable device
US20080085883A1 (en) * 1999-01-25 2008-04-10 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
EP1392328B1 (en) * 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament for protection in radiotherapy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085883A1 (en) * 1999-01-25 2008-04-10 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
US6794371B1 (en) * 1999-10-18 2004-09-21 The Dow Chemical Company Aminoalkylenephosphonates for treatment of bone disorders
EP1392328B1 (en) * 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament for protection in radiotherapy
US20070298354A1 (en) * 2006-06-27 2007-12-27 Ni Ding Carbon coating on an implantable device

Also Published As

Publication number Publication date
ES2355784B1 (es) 2012-02-03
WO2011033163A2 (es) 2011-03-24
EP2492270A4 (en) 2013-01-16
US9145386B2 (en) 2015-09-29
EP2492270B1 (en) 2016-03-09
ES2569239T3 (es) 2016-05-09
ES2355784A1 (es) 2011-03-31
EP2492270A2 (en) 2012-08-29
US20120178730A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
WO2008054585A3 (en) Use of pegylated il-10 to treat cancer
WO2007001883A3 (en) Method to reduce oxidative damage and improve mitochondrial efficiency
WO2012009678A8 (en) Therapeutically active compositions and their method of use
WO2011037643A3 (en) Compositions and methods for detecting and treating prostate carcinoma
WO2007056525A3 (en) High affinity siglec ligands
SG10201809283WA (en) Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
WO2012002760A3 (ko) 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법
WO2007140002A3 (en) Method for treating non-hodgkin's lymphoma
WO2009089494A3 (en) Pharmaceutical compositions
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2011099804A3 (en) Novel antifungal triazole derivatives
WO2008045272A3 (en) Compositions and methods for skin lightening
WO2010027798A3 (en) Ablation devices and related methods thereof
WO2009124330A3 (de) Behandlung von tumorerkrankungen
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
WO2009133374A3 (en) Antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated acid
WO2011130164A3 (en) Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
WO2009158031A3 (en) Methods and compositions for therapeutic treatment
WO2006085932A3 (en) Anti-viral uses of borinic acid complexes
WO2008013966A3 (en) Use of 8-quinolinol and its analogs to target cancer stem cells
WO2009070693A3 (en) Modulators of ocular oxidative stress
WO2008112647A3 (en) Nitroxide radical as a treatment for neurodegeneration
WO2009114703A3 (en) Combination therapy for the treatment of cancer
WO2007100920A3 (en) Diagnosis and treatment of prostate cancer
WO2012004013A3 (en) Glucosinolate transporter protein and uses thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13497135

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2010816744

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10816744

Country of ref document: EP

Kind code of ref document: A1